Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty

Biomaterials
Tajeshwar S AulakhJames B Richardson

Abstract

Impaction grafting using morsellised allograft bone restores bone stock, but carries the potential for transmission of infection. Synthetic bone graft substitutes can eliminate this risk but may, however, influence outcome. In this study we tested the hypothesis that a 50/50 mix of hydroxyapatite and allograft does not affect long-term function, survival or radiological outcome. Sixty-five patients had revision hip arthroplasty using impaction grafting with either pure allograft (42 patients) or a 50/50 mixture of allograft and solid particulate hydroxyapatite. Harris hip scores were assessed pre-operatively and annual intervals thereafter. Function was analyzed using multilevel modeling, the Kaplan-Meier method used for survival analysis and graft incorporation was assessed radiologically. The hip score improved in both groups but showed a small annual decline (average 1.2/year, p<0.01). This decline was higher for females (average 3.4, p=0.025) and significantly related to pre-op scores (p<0.001). After adjusting for these, allograft patients had marginally higher scores (difference=3.1, p=0.3). The majority of revisions were for aseptic loosening. At 13 years survival in the allograft group was 84%, and 82% in the mixture gr...Continue Reading

References

Aug 1, 1997·The Journal of Arthroplasty·J D EldridgeI D Learmonth
Aug 12, 1998·The Journal of Bone and Joint Surgery. British Volume·G GaleaB J Graham
Sep 3, 1999·The Orthopedic Clinics of North America·S Stevenson
Sep 3, 1999·The Orthopedic Clinics of North America·Y Behairy, M Jasty
Jan 1, 2000·The Journal of Bone and Joint Surgery. British Volume·M A RitterM E Berend
Aug 22, 2002·The Journal of Bone and Joint Surgery. British Volume·H EnglishG Gie
Oct 11, 2002·Statistics in Medicine·Harvey GoldsteinJon Rasbash
Nov 1, 2003·The Spine Journal : Official Journal of the North American Spine Society·J S ThalgottZ Klezl
Apr 7, 2004·The Journal of Arthroplasty·Marieke OstendorfAbraham Verbout
Apr 22, 2004·Scandinavian Journal of Public Health·Alastair H Leyland, Peter P Groenewegen
Mar 19, 2005·The Journal of Bone and Joint Surgery. British Volume·A W BlomA E Goodship
Jun 3, 2006·International Orthopaedics·C Nich, L Sedel
Sep 5, 2006·The Journal of Bone and Joint Surgery. American Volume·B Willem SchreursJean W M Gardeniers
Feb 8, 2008·The Journal of Bone and Joint Surgery. British Volume·M CoathupG Blunn
Jul 25, 2009·European Journal of Oral Sciences·Yu-Kang TuMark S Gilthorpe
Mar 2, 2010·The Journal of Bone and Joint Surgery. British Volume·M J B KeelK A Siebenrock

❮ Previous
Next ❯

Citations

Mar 17, 2010·Journal of Materials Science. Materials in Medicine·O BrownF Buchanan
Jul 2, 2010·Tissue Engineering. Part a·Thierry BalaguerNathalie Rochet
Oct 11, 2014·Expert Opinion on Biological Therapy·Zakareya GamieEleftherios Tsiridis
Apr 17, 2012·Expert Opinion on Biological Therapy·Zakareya GamieEleftherios Tsiridis
Jan 7, 2016·The Bone & Joint Journal·Y Fillingham, J Jacobs
Jul 15, 2011·Injury·Andrew Beswick, Ashley W Blom
Nov 7, 2019·Journal of Functional Biomaterials·Gary A FieldingSusmita Bose
Nov 1, 2011·Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine·P J WalshF J Buchanan
Feb 14, 2019·Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy·Daniele MunegatoGiovanni Zatti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.